Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® Birch

NCT01902992 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

202

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinoconjunctivitis

Interventions

DRUG: Depiquick Birch (DPG103)
DRUG: Placebo

Sponsor

Novartis